Equities

HOB Biotech Group Corp Ltd

688656:SHH

HOB Biotech Group Corp Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)123.01
  • Today's Change5.01 / 4.25%
  • Shares traded3.21m
  • 1 Year change+204.25%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments163289455
Total Receivables, Net453843
Total Inventory1118868
Prepaid expenses8.097.673.90
Other current assets, total0.00----
Total current assets328423570
Property, plant & equipment, net595491269
Goodwill, net------
Intangibles, net121312
Long term investments------
Note receivable - long term0.050.100.62
Other long term assets------
Total assets949945864
LIABILITIES
Accounts payable244811
Accrued expenses322829
Notes payable/short-term debt505122
Current portion long-term debt/capital leases4.805.675.51
Other current liabilities, total242019
Total current liabilities13615386
Total long term debt1.039.745.35
Total debt566633
Deferred income tax--0.030.00
Minority interest------
Other liabilities, total1.742.492.40
Total liabilities13916594
SHAREHOLDERS EQUITY
Common stock636363
Additional paid-in capital553551549
Retained earnings (accumulated deficit)194166157
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.290.180.10
Total equity811780770
Total liabilities & shareholders' equity949945864
Total common shares outstanding636363
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.